Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.
Cranston A, Stocken DD, Stamp E, Roblin D, Hamlin J, Langtry J, Plummer R, Ashworth A, Burn J, Rajan N. Cranston A, et al. Among authors: roblin d. Trials. 2017 Mar 7;18(1):111. doi: 10.1186/s13063-017-1812-z. Trials. 2017. PMID: 28270164 Free PMC article. Clinical Trial.
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.
Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, Stones R, Sinclair N, Hodgson K, Bowett SA, Roblin D, Traversa S, Plummer R, Veal G, Langtry JAA, Ashworth A, Burn J, Rajan N. Danilenko M, et al. Among authors: roblin d. JAMA Dermatol. 2018 Aug 1;154(8):913-921. doi: 10.1001/jamadermatol.2018.1610. JAMA Dermatol. 2018. PMID: 29955768 Free PMC article. Clinical Trial.
Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.
Roblin D, Yosipovitch G, Boyce B, Robinson J, Sandy J, Mainero V, Wickramasinghe R, Anand U, Anand P. Roblin D, et al. Acta Derm Venereol. 2015 May;95(5):542-8. doi: 10.2340/00015555-2047. Acta Derm Venereol. 2015. PMID: 25594427 Free article. Clinical Trial.
How does premature ejaculation impact a man s life?
Symonds T, Roblin D, Hart K, Althof S. Symonds T, et al. Among authors: roblin d. J Sex Marital Ther. 2003 Oct-Dec;29(5):361-70. doi: 10.1080/00926230390224738. J Sex Marital Ther. 2003. PMID: 14504007
Anthropometric Measures Among Children and Teens With Classic 46,XX Congenital Adrenal Hyperplasia in Relation to Improvements in Diagnosis and Care.
McCracken C, Kaabi O, Crawford M, Gardner MD, Getahun D, Goodman M, Sorouri Khorashad B, Lash TL, Roblin D, Vupputuri S, Yacoub R, Speiser PW, Lee PA, Sandberg DE. McCracken C, et al. Among authors: roblin d. Endocr Pract. 2024 Sep 12:S1530-891X(24)00671-2. doi: 10.1016/j.eprac.2024.09.005. Online ahead of print. Endocr Pract. 2024. PMID: 39277085
Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study.
Anike O, Zhang Q, Bhasin S, Flanders WD, Getahun D, Haw JS, Huybrechts KF, Lash TL, McCracken CE, Roblin D, Silverberg MJ, Suglia SF, Tangpricha V, Vupputuri S, Goodman M. Anike O, et al. Among authors: roblin d. J Clin Endocrinol Metab. 2024 May 30:dgae353. doi: 10.1210/clinem/dgae353. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38815002
192 results